Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
23 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

DYN — Dyne Therapeutics, Inc. Dilution Risk Tracker

Track DYN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DYN — Get alerts when the score changes →

As of August 28, 2026, Dyne Therapeutics, Inc. (DYN) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Dyne Therapeutics, Inc. has a market capitalization of $3.20B, 186.75M shares outstanding, 232 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊Float Risk—
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DYN.
🔔 Track DYN — Get forecast alerts →

Market Data

Market Cap$3.20B
Shares Outstanding186.75M
FloatN/A
Cash$676.11M
Debt$9.94M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 22.2% shares (2026Q1 vs prior)
232 institutional holders · 223.20M shares
#1 T. Rowe Price Investment Management, Inc. 30.79M shares
#2 JANUS HENDERSON GROUP PLC 27.29M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 12.81M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest21.97M
Days to Cover7.2
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track DYN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DYN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

HON AIG APTV BABAF CMCSA CPT DBD EE GM GTX

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for DYN
DYN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.